Learn More

Moving Theranostics from Bench to Bedside

Recognizing the growing and significant role in delivering precision medicine to patients, the 2018 SNMMI Mid-Winter and ACNM Annual Meeting, taking place January 25-27, 2018 in Orlando, Florida, will feature a dedicated track on Theranostics

IDEAS Webinars and Resources

SNMMI offers a number of free resources on the Imaging Dementia — Evidence for Amyloid Scanning (IDEAS) Study, including helpful links and on-demand webinars.

Targeted Radioisotope Therapy Webinar Series

The new technologies of radionuclide therapy are allowing for personalized treatment of various forms of cancer. Learn more about the clinical utility of these procedures and earn free CE credit.

Healthcare Provider

Welcome to our Healthcare Provider portal. Everything you need to understand the advantages and applications of nuclear medicine and molecular imaging in your practice. Find out more about ordering the right test for the right patient at the right time.

SNMMI's Newly Approved Appropriate Use Criteria

Appropriate Use Criteria (AUC) are statements that contain indications describing when, and how often, an intervention should be performed under the auspices of scientific evidence, clinical judgment, and patient values while avoiding unnecessary provisions of services. SNMMI follows a balanced multidisciplinary approach to guidance development by including various stakeholders in the development process. To view the development process, please click the following link: SNMMI AUC Development Process.



Disease-Specific Information


Cancer Scan


Heart Scan


Brain Scan


SNMMI has created guidelines to identify those elements of the procedure that are most important in obtaining a high-quality examination, Appropriate Use Criteria (AUC), and is working towards optimizing dose.

Appropriate Use Criteria
Dose Optimization

Related Resources

NCCN's Guidelines Tabular Summary
NCCN Practice Guidelines Narrative Summary

Ordering Information

The SNMMI PET Center of Excellence has created a go-to resource with in-depth ordering information and printable materials related to PET and PET/CT, including:

  • Sample Request Forms
  • Sample Letters of Medical Necessity
  • Sample Reports from Nuclear Medicine Physician
  • CMS Decision Memos

Learn More

Request a Speaker

SNMMI is dedicated to providing the community with access to the most knowledgeable and experienced speakers in the field of nuclear medicine and molecular imaging. As part of the new Outreach Program, SNMMI is working to enhance relationships with relevant societies and patient organizations. We have created a pool of speakers who can speak at your next meeting. Please complete the form below to request a speaker.

Outreach Speaker Request Form
Outreach Program



  • March 23, 2018Partial Relief for High-Value Radiopharmaceuticals in Signed Budget Bill

    Buried in the Budget Bill that was just signed into law is a provision that provides some high-value radiopharmaceuticals partial and temporary relief. It also mandates that the Government Accountability Office study the problems with reimbursement for these drugs and report back to Congress.
    (Government Relations News)

  • March 22, 2018Societies Collaborate to Address Differentiated Thyroid Cancer

    Representatives of SNMMI, the European Association of Nuclear Medicine (EANM), the European Thyroid Association (ETA) and American Thyroid Association (ATA) met at the Multilateral Conference on Differentiated Thyroid Cancer and began working collaboratively on issues related to the care of patients with thyroid cancer, with particular focus on radioactive iodine (RAI) therapy.
    (SNMMI News)

  • March 21, 2018SNMMI Seeks Expanded Coverage for NaF PET

    SNMMI, the World Molecular Imaging Society (WMIS), and the American College of Radiology (ACR) are recommending that the Centers for Medicare and Medicaid Services (CMS) reconsider the current restrictive coverage policy for NaF PET imaging to identify bone metastases, which can inform treatment strategy.
    (Government Relations News)

  • March 15, 2018Patient Fly-In for Capitol Hill Advocacy: Bill to Reclassify Diagnostic Radiopharmaceuticals as Drugs

    Patients advocates with a wide range of health conditions—including neuroendocrine tumors, lymphoma and cancers of the lung, breast, and prostate—flew into Washington, DC, for March 14 meetings on Capitol Hill to urge support for a bill that would require the Centers for Medicare & Medicaid Services (CMS) to reclassify diagnostic radiopharmaceuticals as drugs. Patients rely on the radiopharmaceuticals for diagnosing and monitoring their conditions, as well as guiding therapy.
    (Government Relations News)

Featured Resources